Richard Joseph Deslauriers

This inventor holds 36 USPTO granted patents and 24 published patent applications, plus 1 CIPO patent and 3 EPO patents, primarily in Medical Devices. Top assignees: Novocure Gmbh, Doctors Research Group, Inc., Inventure, LLC. Active years: 1998-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard Joseph Deslauriers. Retrieved from https://idiyas.com/inventor/richard-joseph-deslauriers

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 36 (Patent Applications = 24)

% Patents Active = 91.7

CIPO Patents = 1

EPO Patents = 3 (Patent Applications = 12)

Average Co-Inventor Count = 1.4

ph-index = 10

Forward Citations = 1,933(Granted Patents)

Location History:

Waterbury, CT (US) (1998 - 2003)
Southbury, CT (US) (2020)
Woodbury, CT (US) (2005 - 2022)

Company Filing History:

Doctors Research Group, Inc.

Contract Medical Manufacturing LLC

patents

6. 6 out of 834,570

Other

patents

Years Active: 1998-2026

Loading Chart...

Areas of Expertise:

Tumor Treating Fields

Conductive Gels

Surgical Positioning

Transducer Arrays

Medical Procedures

Contrast Agents

Bone Growth

Hydrogel Configurations

Intravenous Delivery

Electrode Arrays

Patient Positioning

Inflatable Speculums

36 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12752109 - Conductive pad generating tumor treating field and methods of production and use thereof (2026-10-06),

2. 12741140 - Wireless transducer arrays applying tumor treating fields and systems and methods of use thereof (2026-09-22),

3. 12721400 - Foot positioning system for surgery (2026-09-01),

4. 12692278 - Synthesis methods and compositions of low intermediate and low dichelate intermediate contrast agents (2026-07-28),

5. 12681086 - Temperature independent method and system for applying TTFields (2026-07-14),

6. 12678615 - Conductive gel compositions and methods of production and use thereof (2026-07-14),

7. 12576265 - Conductive gel compositions and methods of production and use thereof (2026-03-17),

8. 12569677 - Conductive pad incorporating a conductive fabric material (2026-03-10),

9. 12527954 - Method and system for applying tumor treating fields interfacing with hair follicles (2026-01-20),

10. 12496016 - Patient positioning device (2025-12-16),

11. 12478779 - Electrode array having a semi-liquid conductive gel (2025-11-25),

12. 12472353 - Transducer array flexibility and methods of production and use thereof (2025-11-18),

13. 12465760 - Pad generating tumor treating field and having kirigami-like cuts (2025-11-11),

14. 12440671 - Conductive pad with improved air flow and methods of production and use thereof (2025-10-14),

15. 12434052 - Breathable pad generating tumor treating field and methods of production and use thereof (2025-10-07),

Title: **Richard Joseph Deslauriers: Innovator in Cancer Treatment Technologies**

Introduction

Richard Joseph Deslauriers is a prominent inventor based in Woodbury, Connecticut, with a remarkable portfolio of 19 patents. His work primarily focuses on innovative medical technologies, particularly in the treatment of cancer and metastases. Deslauriers' inventions reflect a deep commitment to enhancing patient care through cutting-edge solutions.

Latest Patents

Among Richard Joseph Deslauriers' latest patents is a groundbreaking method for the intravenous, intra-spinal, intra-cavity, and intraventricular delivery of tumor treating fields (TTFields) for treating cancer. This method utilizes six different types of electrodes specifically designed for various applications, including:

1. **Insertion into blood vessels** to contact blood.

2. **Insertion into the central canal of the spinal cord** to interact with cerebrospinal fluid (CSF).

3. **Insertion into body orifices** to contact the interior surfaces.

4. **Affixation to the skin** for external treatment.

5. **Insertion into brain ventricles** to engage with CSF.

6. **Insertion into lymph vessels** for lymphatic contact.

The application of an alternating current voltage between these electrodes creates TTFields in designated areas of the body, offering a novel approach to cancer therapy. Additionally, Deslauriers has developed improved hydrogel configurations for use with TTField-generating systems, which include kits and methods for their production and application.

Career Highlights

Richard Joseph Deslauriers has made significant contributions to the field of medical technology through his patents and research. His innovative spirit has positioned him as a key player in the evolving landscape of cancer treatment technologies, proving instrumental in developing new therapeutic methods.

Collaborations

Throughout his career, Deslauriers has collaborated with noteworthy individuals such as Eric D. Kolb and Robert T. Potash. Working alongside such accomplished professionals has further advanced his research and innovation in the medical field.

Conclusion

Richard Joseph Deslauriers continues to be a driving force in the development of advanced treatment technologies for cancer. With a solid number of patents to his name and a dedicated approach to innovation, he exemplifies the spirit of invention that can lead to transformative therapies in medicine. His work not only contributes to the understanding of cancer treatment but also provides hope for patients facing daunting health challenges.

Profile summary based on public USPTO records.